Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hericium erinaceus is a tooth fungus species found on hardwood trees in North America and Eurasia, recognized for its fleshy, dangling spines. It is famous for its potential medicinal benefits as an edible mushroom, with active constituents like hericenones and erinacines that have neuroprotective, anti-inflammatory, and immune-enhancing properties. These bioactives stimulate neurotrophin production (e.g., nerve growth factor NGF, brain-derived neurotrophic factor BDNF) and modulate signaling pathways related to cell survival and neuroinflammation. While extensively researched for effects on the brain and immune system, it is not a molecular or receptor target; rather, it is a source of bioactive compounds that may act on various molecular targets in humans.
The fungus is not itself a drug target; its neuroprotective, anti-inflammatory, and antioxidative effects are mediated by its secondary metabolites, which influence pathways such as neurotrophin signaling, anti-cytokine effects, and oxidative stress pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hericium erinaceus.